In the field of modern animal husbandry and veterinary medicine, parasitic diseases have always been a key challenge that threatens animal health and affects breeding benefits. As a new generation of veterinary antiparasitic preparations, 1% Ivermectin Injection (SINIVER 1%) provides professional and efficient solutions for large-scale breeding and pet medical care with its excellent pharmacological properties and clinical value.

1. Precise mechanism of action, targeted parasite expulsion and killing
The action of ivermectin is based on a unique neurobiological principle: by enhancing the release of γ-aminobutyric acid (GABA) in presynaptic neurons of parasites, activating chloride ion channels, blocking nerve-muscle signaling, and causing the parasite to relax and paralyze, losing its pathogenicity. This mechanism is different from traditional anthelmintics, and has a broad spectrum of anthelmintic activity against internal and external parasites - covering gastrointestinal nematodes (such as roundworms, hookworms), lung nematodes, and external mites (scabies, itch mites), ticks, lice, etc., and is not easy to produce cross-resistance with other target drugs, laying a solid foundation for long-term prevention and control of parasitic diseases.

2. Clinical efficacy verification: high efficiency, long-term and safe
(I) Wide spectrum of anthelmintics, covering the needs of multiple species
Adaptable to cattle, sheep, pigs, dogs, cats and other animals, and achieve a "one-stop" solution for common mixed infections in large-scale farms (such as pig roundworm + scabies combined infection, sheep lung nematode + tick infection). Clinical data show that the expulsion rate of sheep Chabert nematodes, pig red roundworms and other adults and larvae is 94% - 100%, significantly relieving symptoms such as weight loss, diarrhea, and skin itching, and quickly restoring animal growth performance.
(II) Long-acting sustained release, simplified drug administration process
After subcutaneous/muscular injection, the injection solution slowly releases the drug in the animal body, and the effective blood drug concentration can last for several days to weeks, reducing the stress of frequent administration. Compared with oral preparations, it avoids the problems of poor palatability and unstable intestinal absorption, ensures accurate dosage and stable efficacy, and is especially suitable for standardized management in large-scale breeding scenarios.
(III) High safety threshold, adaptable to multiple physiological stages
At the recommended dose, it has little effect on the liver and kidney function of animals, and most animals have no obvious adverse reactions. Although attention should be paid to the gene-specific risks of sensitive breeds such as Collies (MDR1 mutant individuals need to adjust the dose), the overall safety range is wide, which can cover young and pregnant animals (follow the doctor's advice) and ensure the drug demand for the entire breeding cycle.

III. Core advantages of the product: empowering breeding benefits
(I) Reducing costs and increasing efficiency, optimizing the production chain
Reducing complications: Removing parasites can reduce the risk of secondary infections (such as tick-borne blood diseases and mite-induced dermatitis) and reduce the cost of combined antibiotics.
Improve growth efficiency: Eliminate the plunder of nutrients by parasites, return the weight gain and lactation performance of livestock and poultry to normal levels, and significantly improve the skin health and quality of life of pets.
(II) Compliance residue control to ensure food safety
Strictly follow the drug metabolism kinetics design and clarify the drug withdrawal period specifications. Under reasonable use, the residue of animal-derived food (meat, milk, etc.) is lower than the national standard limit, helping the breeding end to pass the food safety traceability system and meet the market demand for "antibiotic-free" and "low residue" products.
(III) Dosage form and process innovation to adapt to scene requirements
The 100mL large-capacity bottle design takes into account the needs of "group administration" in large-scale fields and "precision treatment" in pet clinical practice; the high-purity preparation process ensures the stability of the drug, and the drug efficacy can be maintained by storing in a cool and dry environment, reducing logistics and storage costs.

1% Ivermectin injection redefines the animal parasite prevention and control program with its academic-level anthelmintic mechanism, clinically proven high efficiency and adaptability to breeding scenarios. Whether it is the trinity of "cost reduction - efficiency improvement - compliance" pursued by intensive farms, or the demand for "safety - long-term - convenience" in pet medicine, this product can provide professional support. Choosing SINIVER 1% means choosing to use cutting-edge veterinary medicine technology to protect animal health and create dual value for breeding benefits and animal welfare.

• Previous：Tilmicosin Injection 30% - A macrolide antibiotic, a broad-spectrum semi-synthetic bactericidal antibiotic
• Next：A broad spectrum anthelmintic - Albendazole 2500mg